相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of single nucleotide polymorphisms (R132Q and W120R) on the binding affinity and metabolic activity of CYP2C19 toward some therapeutically important substrates
Sayed M. Derayea et al.
XENOBIOTICA (2020)
Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry
Yujuan Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice
Ajeeth K. Pingili et al.
HYPERTENSION (2016)
Genotype-phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy
Tianbo Jin et al.
MOLECULAR MEDICINE REPORTS (2016)
Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia
Wen-Yao Zhu et al.
SCIENTIFIC REPORTS (2016)
Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers newsubstrate specificity towards flavonoids
Tomohide Uno et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2015)
Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation
M. Takahashi et al.
PHARMACOGENOMICS JOURNAL (2015)
Heterologous expression of human cytochrome P450 (CYP) 2C19 in Escherichia coli and establishment of RP-HPLC method to serve as activity marker
Yan Pan et al.
BIOMEDICAL CHROMATOGRAPHY (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Structural Characterization of Human Cytochrome P450 2C19 ACTIVE SITE DIFFERENCES BETWEEN P450s 2C8, 2C9, AND 2C19
R. Leila Reynald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population
Li-Ming Hu et al.
PHARMACOGENOMICS (2012)
Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
Huijuan Wang et al.
DRUG METABOLISM AND DISPOSITION (2011)
16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Karl-Heinz Storbeck et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Characterization of the genetic profile of CYP2C19 in two South African populations
Britt I. Drogemoeller et al.
PHARMACOGENOMICS (2010)
Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole
Su-Jun Lee et al.
DRUG METABOLISM AND DISPOSITION (2009)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese
Q. Zhou et al.
PHARMACOGENOMICS JOURNAL (2009)
Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450
Maude Fer et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Bioconversion of small molecules by cytochrome P450 species expressed in Escherichia coli
Tomohide Uno et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2008)
Important amino acid residues that confer CYP2C19 selective activity to CYP2C9
Yasunobu Wada et al.
JOURNAL OF BIOCHEMISTRY (2008)
The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance
J. Rosemary et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
N. Hanioka et al.
XENOBIOTICA (2007)
Multiple molecular dynamics simulations of human P450 monooxygenase CYP2C9: The molecular basis of substrate binding and regioselectivity toward warfarin
Alexander Seifert et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.)
Jian Guo et al.
DRUG METABOLISM AND DISPOSITION (2006)
Characterization of testosterone 11β-hydroxylation catalyzed by human liver microsomal cytochromes P450
MH Choi et al.
DRUG METABOLISM AND DISPOSITION (2005)
The structure of human cytochrome P4502C9 complexed with flurbiprofen at 2.0-Å resolution
MR Wester et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The involvement of CYP3A4 and CYP2C9 in the metabolism of 17α-ethinylestradiol
B Wang et al.
DRUG METABOLISM AND DISPOSITION (2004)
Crystal structure of human cytochrome P4502C9 with bound warfarin
PA Williams et al.
NATURE (2003)
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles
C Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
